Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
YD Bio launches telehealth platform for cancer detection By Investing.com
YD Bio Limited has announced the launch of its EG Telehealth Platform in collaboration with EG BioMed Co., Ltd., expanding cancer detection and monitoring services across 44 U.S. states, Washington, D.C., and Guam. This platform combines YD Bio’s digital health infrastructure with EG BioMed’s laboratory capabilities to screen for various cancers, including pancreatic, colorectal, liver, gastrointestinal, and breast cancers. The launch is a step towards scalable deployment, coinciding with YD Bio’s ongoing plans to merge with EG BioMed and recent acquisitions to enhance its technological capabilities.